USPTO serial 79434062
GENFIT TOWARDS BETTER MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2026
- Examiner
- SHERMAN, GENEVA R
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENFIT TOWARDS BETTER MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; chemical preparations for medical use, for pharmaceutical use, for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; biological preparations for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; biological preparations for use in cell cultures for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer for gene therapy and cell therapy; diagnostic and research kits for preparing cells and for selecting biologically active compounds; diagnostic products for medical or veterinary use, namely, diagnostic assay kits and reagents for medical or veterinary use; diagnostic reagents for medical or veterinary use; medical diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 9, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 14, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 14, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 17, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 2, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |